News Boehringer looks to cancer immunotherapy combinations BI developing combinations with its own checkpoint inhibitors
Events Partner Content Rational Combinations 360° The Conference Forum is delighted to present the 2nd annual Rational Combinations 360°, the only event addressing business aspects, novel clinical trial designs and scientific deve
News Kite keeps pressure on Novartis with CAR-T filing Kite completes filing a day after rival Novartis.
News NHS to axe 18-week ops waiting target Cancer care and mental health to take priority, says health chief.
News AZ's Tagrisso gets full US approval in lung cancer Phase 3 data confirmed its efficacy in patients with a certain mutation.
News Novartis edges ahead in CAR-T race Novartis has filed its CAR-T cell therapy with the FDA, giving it an edge over Kite Pharma and its rival treatment.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
